Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 43, Issue 5 (April 2018) In this issue Commentaries Perspective Review Article Original Articles In Memoriams Also new AOP   Commentaries Parvalbumin-Expressing Neurons in the Nucleus Accumbens: A New Player in Amphetamine Sensitization and Reward Brandon L Warren & Leslie R Whitaker Neuropsychopharmacology 2017 43 :929 - 930; August 17, 2017; 10.1038/npp.2017.256   Abstract | Full Text Too Depressed to Swim or Too Afraid to Stop? A Reinterpretation of the Forced Swim Test as a Measure of Anxiety-Like Behavior Jeffrey Anyan & Shimon Amir Neuropsychopharmacology 2017 43 :931 - 933; October 31, 2017; 10.1038/npp.2017.260   Abstract | Full Text Perspective CNO Evil? Considerations for the Use of DREADDs in Behavioral Neuroscience Stephen V Mahler & Gary Aston-Jones Neuropsychopharmacology 2018 43 :934 - 936; February 07, 2018; 10.1038/npp.2017.299   Abstract | Full Text Review Article Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive Ada Eban-Rothschild, Lior Appelbaum & Luis de Lecea Neuropsychopharmacology 2017 43 :937 - 952; December 05, 2017; 10.1038/npp.2017.294   Abstract | Full Text Original Articles Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference Xiaoting Wang, David A Gallegos, Vladimir M Pogorelov, Justin K O'Hare, Nicole Calakos et al. Neuropsychopharmacology 2017 43 :953 - 963; August 25, 2017; 10.1038/npp.2017.178   Abstract | Full Text Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum Estefanía Moreno, Anna Chiarlone, Mireia Medrano, Mar Puigdellívol, Lucka Bibic et al. Neuropsychopharmacology 2017 43 :964 - 977; January 19, 2017; 10.1038/npp.2017.12   Abstract | Full Text Pituitary Adenylate Cyclase-Activating Peptide in the Bed Nucleus of the Stria Terminalis Mediates Stress-Induced Reinstatement of Cocaine Seeking in Rats Olivia W Miles, Eric A Thrailkill, Anne K Linden, Victor May, Mark E Bouton et al. Neuropsychopharmacology 2017 43 :978 - 986; June 28, 2017; 10.1038/npp.2017.135   Abstract | Full Text Dorsal Hippocampus Drives Context-Induced Cocaine Seeking via Inputs to Lateral Septum Ellen M McGlinchey & Gary Aston-Jones Neuropsychopharmacology 2017 43 :987 - 1000; July 11, 2017; 10.1038/npp.2017.144   Abstract | Full Text Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine Taylor A Gentile, Steven J Simmons, Mia N Watson, Krista L Connelly, Eugen Brailoiu et al. Neuropsychopharmacology 2017 43 :1001 - 1009; July 25, 2017; 10.1038/npp.2017.158   Abstract | Full Text Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence Alessandra Matzeu, Marsida Kallupi, Olivier George, Paul Schweitzer & Rémi Martin-Fardon Neuropsychopharmacology 2017 43 :1010 - 1020; October 20, 2017; 10.1038/npp.2017.250   Abstract | Full Text Hippocampal Protein Kinase C Signaling Mediates the Short-Term Memory Impairment Induced by Delta9-Tetrahydrocannabinol Arnau Busquets-Garcia, Maria Gomis-González, Victòria Salgado-Mendialdúa, Lorena Galera-López, Emma Puighermanal et al. Neuropsychopharmacology 2017 43 :1021 - 1031; August 17, 2017; 10.1038/npp.2017.175   Abstract | Full Text Selective Lesioning of Nuclear Factor-?B Activated Cells in the Nucleus Accumbens Shell Attenuates Alcohol Place Preference S E Nennig, H D Fulenwider, S H Chimberoff, B M Smith, J E Eskew et al. Neuropsychopharmacology 2017 43 :1032 - 1040; September 13, 2017; 10.1038/npp.2017.214   Abstract | Full Text Structural and Functional Characterization of the Interaction of Snapin with the Dopamine Transporter: Differential Modulation of Psychostimulant Actions Amaia M Erdozain, Stéphanie De Gois, Véronique Bernard, Victor Gorgievski, Nicolas Pietrancosta et al. Neuropsychopharmacology 2017 43 :1041 - 1051; September 14, 2017; 10.1038/npp.2017.217   Abstract | Full Text The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study Christine M Sandiego, David Matuskey, Meaghan Lavery, Erin McGovern, Yiyun Huang et al. Neuropsychopharmacology 2017 43 :1052 - 1058; September 25, 2017; 10.1038/npp.2017.223   Abstract | Full Text Incubation of Accumbal Neuronal Reactivity to Cocaine Cues During Abstinence Predicts Individual Vulnerability to Relapse Karine Guillem & Serge H Ahmed Neuropsychopharmacology 2017 43 :1059 - 1065; September 18, 2017; 10.1038/npp.2017.224   Abstract | Full Text VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward Xiaojie Liu, Yan Li, Laikang Yu, Casey R Vickstrom & Qing-song Liu Neuropsychopharmacology 2017 43 :1066 - 1077; October 17, 2017; 10.1038/npp.2017.247   Abstract | Full Text SMRI Biomarkers Predict Electroconvulsive Treatment Outcomes: Accuracy with Independent Data Sets Rongtao Jiang, Christopher C Abbott, Tianzi Jiang, Yuhui Du, Randall Espinoza et al. Neuropsychopharmacology 2017 43 :1078 - 1087; July 31, 2017; 10.1038/npp.2017.165   Abstract | Full Text Narp Mediates Antidepressant-Like Effects of Electroconvulsive Seizures Andrew D Chang, Punit V Vaidya, Edward P Retzbach, Sunho J Chung, Urian Kim et al. Neuropsychopharmacology 2017 43 :1088 - 1098; October 20, 2017; 10.1038/npp.2017.252   Abstract | Full Text Prefrontal Cortex Deep Brain Stimulation Improves Fear and Anxiety-Like Behavior and Reduces Basolateral Amygdala Activity in a Preclinical Model of Posttraumatic Stress Disorder Roman Reznikov, Francis Rodriguez Bambico, Mustansir Diwan, Roger J Raymond, Mina G Nashed et al. Neuropsychopharmacology 2017 43 :1099 - 1106; September 01, 2017; 10.1038/npp.2017.207   Abstract | Full Text Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans Amelia Draper, Rebecca M Koch, Jos WM van der Meer, Matthew AJ Apps, Peter Pickkers et al. Neuropsychopharmacology 2017 43 :1107 - 1118; September 26, 2017; 10.1038/npp.2017.231   Abstract | Full Text Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder Dustin Scheinost, Sophie E Holmes, Nicole DellaGioia, Charlie Schleifer, David Matuskey et al. Neuropsychopharmacology 2017 43 :1119 - 1127; September 25, 2017; 10.1038/npp.2017.229   Abstract | Full Text The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder Xiao Xiao, Fanfan Zheng, Hong Chang, Yina Ma, Yong-Gang Yao et al. Neuropsychopharmacology 2017 43 :1128 - 1137; October 09, 2017; 10.1038/npp.2017.241   Abstract | Full Text Epigenetic Changes of FKBP5 as a Link Connecting Genetic and Environmental Risk Factors with Structural and Functional Brain Changes in Major Depression Leonardo Tozzi, Chloe Farrell, Linda Booij, Kelly Doolin, Zsofia Nemoda et al. Neuropsychopharmacology 2017 43 :1138 - 1145; November 28, 2017; 10.1038/npp.2017.290   Abstract | Full Text Pregenual Anterior Cingulate Dysfunction Associated with Depression in OCD: An Integrated Multimodal fMRI/1H MRS Study Reza Tadayonnejad, Rangaprakash Deshpande, Olusola Ajilore, Teena Moody, Francesca Morfini et al. Neuropsychopharmacology 2017 43 :1146 - 1155; October 20, 2017; 10.1038/npp.2017.249   Abstract | Full Text Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala Thomas Grund & Inga D Neumann Neuropsychopharmacology 2017 43 :1156 - 1163; August 14, 2017; 10.1038/npp.2017.169   Abstract | Full Text Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and ß-Arrestin to Dopamine-Dependent Functions Samuel J Rose, Thomas F Pack, Sean M Peterson, Kaitlin Payne, Emiliana Borrelli et al. Neuropsychopharmacology 2017 43 :1164 - 1173; October 25, 2017; 10.1038/npp.2017.254   Abstract | Full Text The New News about Lithium: An Underutilized Treatment in the United States Robert M Post Neuropsychopharmacology 2017 43 :1174 - 1179; October 04, 2017; 10.1038/npp.2017.238   Abstract | Full Text Brain-Behavior Participant Similarity Networks Among Youth and Emerging Adults with Schizophrenia Spectrum, Autism Spectrum, or Bipolar Disorder and Matched Controls Laura Stefanik, Lauren Erdman, Stephanie H Ameis, George Foussias, Benoit H Mulsant et al. Neuropsychopharmacology 2017 43 :1180 - 1188; November 06, 2017; 10.1038/npp.2017.274   Abstract | Full Text In Memoriams Larry J Seidman Matcheri S Keshavan Neuropsychopharmacology 2018 43 :1189 - 1190; March 14, 2018; 10.1038/npp.2017.288   Abstract | Full Text Pamela Sklar Alexander W Charney Neuropsychopharmacology 2018 43 :1191 - 1192; March 14, 2018; 10.1038/npp.2018.1   Abstract | Full Text Dennis L Murphy, MD James B. Potash, Andrew Holmes & Anne Milasincic Andrews Neuropsychopharmacology 2018 43 :1193 - 1194; March 14, 2018; 10.1038/npp.2018.2   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.